Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

The efficacy of tocilizumab was tested in a randomized, controlled trial involving patients with Covid-19 who had fever, pulmonary infiltrates, or a need for supplemental oxygen. The treatment had no significant effect on disease progression, independence from supplemental oxygen, or death.

Uloženo v:
Podrobná bibliografie
Vydáno v:The New England journal of medicine Ročník 383; číslo 24; s. 2333 - 2344
Hlavní autoři: Stone, John H, Frigault, Matthew J, Serling-Boyd, Naomi J, Fernandes, Ana D, Harvey, Liam, Foulkes, Andrea S, Horick, Nora K, Healy, Brian C, Shah, Ruta, Bensaci, Ana Maria, Woolley, Ann E, Nikiforow, Sarah, Lin, Nina, Sagar, Manish, Schrager, Harry, Huckins, David S, Axelrod, Matthew, Pincus, Michael D, Fleisher, Jorge, Sacks, Chana A, Dougan, Michael, North, Crystal M, Halvorsen, Yuan-Di, Thurber, Tara K, Dagher, Zeina, Scherer, Allison, Wallwork, Rachel S, Kim, Arthur Y, Schoenfeld, Sara, Sen, Pritha, Neilan, Tomas G, Perugino, Cory A, Unizony, Sebastian H, Collier, Deborah S, Matza, Mark A, Yinh, Janeth M, Bowman, Kathryn A, Meyerowitz, Eric, Zafar, Amna, Drobni, Zsofia D, Bolster, Marcy B, Kohler, Minna, D’Silva, Kristin M, Dau, Jonathan, Lockwood, Megan M, Cubbison, Caroline, Weber, Brittany N, Mansour, Michael K
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Massachusetts Medical Society 10.12.2020
Témata:
ISSN:0028-4793, 1533-4406, 1533-4406
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Buďte první, kdo okomentuje tento záznam!
Nejprve se musíte přihlásit.